Myxoinflammatory fibroblastic sarcoma (MIFS) is a rare soft tissue tumor first reported in 1998, and subsequently described under three different names: "inflammatory myxohyaline tumor of distal extremities with virocyte or Reed-Sternberg-like cells", "acral myxoinflammatory fibroblastic sarcoma" and "inflammatory myxoid tumor of the soft parts with bizarre giant cells".[1] It most frequently occurs in the limbs of adult patients, not always in acral locations. 7 Liu H, Sukov W, Ro J. The t(1;10)(p22;q24)TGFBR3/MGEA5 translocation in pleomorphic hyalinizing angiectatic tumor, myxoinflammatory fibroblastic sarcoma, and hemosiderotic fibrolipomatous tumor. 8 Boland J, Folpe A. Hemosiderotic fibrolipomatous tumor, pleomorphic hyalinizing angiectatic tumor, and myxoinflammatory fibroblastic sarcoma. [Extracted from the article]